Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asmita Das

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|September 14, 2010
Lytic granule polarization, rather than degranulation, is the preferred target of inhibitory receptors in NK cellsAsmita Das, Eric O Long
Life Sciences|July 28, 2020
Combinatorial drug therapy in cancer - New insightsKaranpreet Bhatia, Bhumika, Asmita Das
Journal of Biomolecular Structure & Dynamics|October 27, 2023
"Cholinergic side Effect-Free anticancer drugs: paving the way for safer and more effective cancer treatment"Ritu, Prakash Chandra, Asmita Das
Clinical and Experimental Medicine|October 7, 2023
Immune checkpoint targeting antibodies hold promise for combinatorial cancer therapeuticsRitu, Prakash Chandra, Asmita Das
Immunology Letters|July 28, 2004
Role of interaction between Ly49 inhibitory receptors and cognate MHC I molecules in IL2-induced development of NK cells in murine bone marrow cell culturesAsmita Das, Rajiv K Saxena
Journal of Photochemistry and Photobiology. B, Biology|April 30, 2017
Correlation of binding efficacies of DNA to flavonoids and their induced cellular damageAsmita Das, Debashis Majumder, Chabita Saha
International Journal of Biological Macromolecules|July 1, 2017
Catalase inhibition an anti cancer property of flavonoids: A kinetic and structural evaluationDebashis Majumder, Asmita Das, Chabita Saha
Immunologic Research|May 13, 2022
Thyroid receptor β might be responsible for breast cancer associated with Hashimoto's thyroiditis: a new insight into pathogenesisMuskaan Dhingra, Shayon Mahalanobis, Asmita Das
Anti-Cancer Drugs|May 14, 2024
Combating anoikis resistance: bioactive compounds transforming prostate cancer therapyShweta Gulia, Prakash Chandra, Asmita Das
Current Computer-Aided Drug Design|February 20, 2024
Natural Compound Dioscin Targeting Multiple Cancer Pathways through its High Affinity Binding to B Cell Lymphoma-2Shweta Gulia, Prakash Chandra, Asmita Das
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Journal of Immunology (Baltimore, Md. : 1950)|September 14, 2010
Lytic granule polarization, rather than degranulation, is the preferred target of inhibitory receptors in NK cellsAsmita Das, Eric O Long
Life Sciences|July 28, 2020
Combinatorial drug therapy in cancer - New insightsKaranpreet Bhatia, Bhumika, Asmita Das
Journal of Biomolecular Structure & Dynamics|October 27, 2023
"Cholinergic side Effect-Free anticancer drugs: paving the way for safer and more effective cancer treatment"Ritu, Prakash Chandra, Asmita Das
Clinical and Experimental Medicine|October 7, 2023
Immune checkpoint targeting antibodies hold promise for combinatorial cancer therapeuticsRitu, Prakash Chandra, Asmita Das
Immunology Letters|July 28, 2004
Role of interaction between Ly49 inhibitory receptors and cognate MHC I molecules in IL2-induced development of NK cells in murine bone marrow cell culturesAsmita Das, Rajiv K Saxena
Journal of Photochemistry and Photobiology. B, Biology|April 30, 2017
Correlation of binding efficacies of DNA to flavonoids and their induced cellular damageAsmita Das, Debashis Majumder, Chabita Saha
International Journal of Biological Macromolecules|July 1, 2017
Catalase inhibition an anti cancer property of flavonoids: A kinetic and structural evaluationDebashis Majumder, Asmita Das, Chabita Saha
Immunologic Research|May 13, 2022
Thyroid receptor β might be responsible for breast cancer associated with Hashimoto's thyroiditis: a new insight into pathogenesisMuskaan Dhingra, Shayon Mahalanobis, Asmita Das
Anti-Cancer Drugs|May 14, 2024
Combating anoikis resistance: bioactive compounds transforming prostate cancer therapyShweta Gulia, Prakash Chandra, Asmita Das
Current Computer-Aided Drug Design|February 20, 2024
Natural Compound Dioscin Targeting Multiple Cancer Pathways through its High Affinity Binding to B Cell Lymphoma-2Shweta Gulia, Prakash Chandra, Asmita Das
Pageof 5